The pathophysiology of hypertension in patients with obesity (original) (raw)

• Malik, V. S., Willett, W. C. & Hu, F. B. Global obesity: trends, risk factors and policy implications. Nat. Rev. Endocrinol. 9, 13–27 (2013).
  PubMed Google Scholar
• Thomsen, B. L., Ekstrøm, C. T. & Sørensen, T. I. Development of the obesity epidemic in Denmark: cohort, time and age effects among boys born 1930–1975. Int. J. Obes. Relat. Metab. Disord. 23, 693–701 (1999).
  CAS PubMed Google Scholar
• Heimburger, D. C. et al. A festschrift for Roland L. Weinsier: nutrition scientist, educator, and clinician. Obes. Res. 11, 1246–1262 (2003).
  PubMed Google Scholar
• Keith, S. W. et al. Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int. J. Obes (Lond.) 30, 1585–1594 (2006).
  CAS Google Scholar
• McAllister, E. J. et al. Ten putative contributors to the obesity epidemic. Crit. Rev. Food Sci. Nutr. 49, 868–913 (2009).
  PubMed PubMed Central Google Scholar
• Sørensen, T. I. Conference on “Multidisciplinary approaches to nutritional problems”. Symposium on “Diabetes and health”. Challenges in the study of causation of obesity. Proc. Nutr. Soc. 68, 43–54 (2009).
  PubMed Google Scholar
• Sowers, J. R. Diabetes mellitus and vascular disease. Hypertension 61, 943–947 (2013).
  CAS PubMed Google Scholar
• Flegal, K. M., Carroll, M. D., Ogden, C. L. & Curtin, L. R. Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303, 235–241 (2010).
  CAS PubMed Google Scholar
• Ogden, C. L. et al. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295, 1549–1555 (2006).
  CAS PubMed Google Scholar
• Sowers, J. R., Whaley-Connel, A. T. & Hayden, M. R. The role of overweight and obesity in the cardiorenal syndrome. Cardiorenal Med. 1, 5–12 (2011).
  PubMed PubMed Central Google Scholar
• Yach, D., Stuckler, D. & Brownell, K. D. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat. Med. 12, 62–66 (2006).
  CAS PubMed Google Scholar
• Kannel, W. B., Brand, N., Skinner, J. J. Jr, Dawber, T. R. & McNamara, P. M. The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann. Intern. Med. 67, 48–59 (1967).
  CAS PubMed Google Scholar
• Bramlage, P. et al. Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am. J. Hypertens. 17, 904–910 (2004).
  PubMed Google Scholar
• Krauss, R. M., Winston, M., Fletcher, B. J. & Grundy, S. M. Obesity: impact on cardiovascular disease. Circulation 98, 1472–1476 (1998).
  PubMed Google Scholar
• Garrison, R. J., Kannel, W. B., Stokes, J. 3rd & Castelli, W. P. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev. Med. 16, 235–251 (1987).
  CAS PubMed Google Scholar
• Brown, C. D. et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes. Res. 8, 605–619 (2000).
  CAS PubMed Google Scholar
• Shihab, H. M. et al. Body mass index and risk of incident hypertension over the life course: the Johns Hopkins Precursors Study. Circulation 126, 2983–2989 (2012).
  PubMed PubMed Central Google Scholar
• Droyvold, W. B., Midthjell, K., Nilsen, T. I. & Holmen, J. Change in body mass index and its impact on blood pressure: a prospective population study. Int. J. Obes. (Lond.) 29, 650–655 (2005).
  CAS Google Scholar
• Vague, J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am. J. Clin. Nutr. 4, 20–34 (1956).
  CAS PubMed Google Scholar
• Kissebah, A. H. et al. Relation of body fat distribution to metabolic complications of obesity. J. Clin. Endocrinol. Metab. 54, 254–260 (1982).
  CAS PubMed Google Scholar
• Krotkiewski, M., Björntorp, P., Sjöström, L. & Smith, U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J. Clin. Invest. 72, 1150–1162 (1983).
  CAS PubMed PubMed Central Google Scholar
• Cassano, P. A., Segal, M. R., Vokonas, P. S. & Weiss, S. T. Body fat distribution, blood pressure, and hypertension. A prospective cohort study of men in the normative aging study. Ann. Epidemiol. 1, 33–48 (1990).
  CAS PubMed Google Scholar
• Lapidus, L. et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br. Med. J. (Clin. Res. Ed.) 289, 1257–1261 (1984).
  CAS Google Scholar
• Larsson, B. et al. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br. Med. J. (Clin. Res. Ed.) 288, 1401–1404 (1984).
  CAS Google Scholar
• Alberti, K. G. & Zimmet, P. Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15, 539–553 (1998).
  CAS PubMed Google Scholar
• Alberti, K. G. et al. Harmonizing the metabolic syndrome. A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640–1645 (2009).
  CAS PubMed Google Scholar
• Neter, J. E., Stam, B. E., Kok, F. J., Grobbee, D. E. & Geleijnse, J. M. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 42, 878–884 (2003).
  CAS PubMed Google Scholar
• Appel, L. J. et al. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 47, 296–308 (2006).
  CAS PubMed Google Scholar
• Landsberg, L. et al. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment—a position paper of the The Obesity Society and The American Society of Hypertension. Obesity (Silver Spring) 21, 8–24 (2013).
  Google Scholar
• Kotchen, T. A. Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am. J. Hypertens. 23, 1170–1178 (2010).
  CAS PubMed Google Scholar
• Esler, M. et al. Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 48, 787–796 (2006).
  CAS PubMed Google Scholar
• Henry, S. L. et al. Developmental origins of obesity-related hypertension. Clin. Exp. Pharmacol. Physiol. 39, 799–806 (2012).
  CAS PubMed Google Scholar
• Rumantir, M. S. et al. Neural mechanisms in human obesity-related hypertension. J. Hypertens. 17, 1125–1133 (1999).
  CAS PubMed Google Scholar
• Grassi, G. et al. Adrenergic and reflex abnormalities in obesity-related hypertension. Hypertension 36, 538–542 (2000).
  CAS PubMed Google Scholar
• Zhao, D. et al. Dietary factors associated with hypertension. Nat. Rev. Cardiol. 8, 456–465 (2011).
  CAS PubMed Google Scholar
• Aghamohammadzadeh, R. & Heagerty, A. M. Obesity-related hypertension: epidemiology, pathophysiology, treatments, and the contribution of perivascular adipose tissue. Ann. Med. 44 (Suppl. 1), S74–S84 (2012).
  CAS PubMed Google Scholar
• Johnson, R. J. et al. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes 62, 3307–3315 (2013).
  CAS PubMed PubMed Central Google Scholar
• Jordan, J. et al. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension. J. Hypertens. 30, 1047–1055 (2012).
  CAS PubMed Google Scholar
• Messerli, F. H. et al. Disparate cardiovascular findings in men and women with essential hypertension. Ann. Intern. Med. 107, 158–161 (1987).
  CAS PubMed Google Scholar
• Aroor, A. R., McKarns, S., Demarco, V. G., Jia, G. & Sowers, J. R. Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance. Metabolism 62, 1543–1552 (2013).
  CAS PubMed Google Scholar
• Huxley, R., Barzi, F. & Woodward, M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 332, 73–78 (2006).
  PubMed PubMed Central Google Scholar
• Barrett-Connor, E. et al. Women and heart disease: the role of diabetes and hyperglycemia. Arch. Intern. Med. 164, 934–942 (2004).
  PubMed Google Scholar
• Howard, B. V. et al. Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study. Diabetes Care 21, 1258–1265 (1998).
  CAS PubMed Google Scholar
• Okosun, I. S., Prewitt, T. E. & Cooper, R. S. Abdominal obesity in the United States: prevalence and attributable risk of hypertension. J. Hum. Hypertens. 13, 425–430 (1999).
  CAS PubMed Google Scholar
• Huang, Z. et al. Body weight, weight change, and risk for hypertension in women. Ann. Intern. Med. 128, 81–88 (1998).
  CAS PubMed Google Scholar
• Engeli, S. et al. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45, 356–362 (2005).
  CAS PubMed Google Scholar
• Li, M., Sloboda, D. M. & Vickers, M. H. Maternal obesity and developmental programming of metabolic disorders in offspring: evidence from animal models. Exp. Diabetes Res. 2011, 592408 (2011).
  CAS PubMed PubMed Central Google Scholar
• Fullston, T. et al. Paternal obesity initiates metabolic disturbances in two generations of mice with incomplete penetrance to the F2 generation and alters the transcriptional profile of testis and sperm microRNA content. FASEB J. 27, 4226–4243 (2013).
  CAS PubMed Google Scholar
• Bray, G. A., Nielsen, S. J. & Popkin, B. M. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am. J. Clin. Nutr. 79, 537–543 (2004).
  CAS PubMed Google Scholar
• Khitan, Z. & Kim, D. H. Fructose: a key factor in the development of metabolic syndrome and hypertension. J. Nutr. Metab. 2013, 682673 (2013).
  PubMed PubMed Central Google Scholar
• Hallfrisch, J. Metabolic effects of dietary fructose. FASEB J. 4, 2652–2660 (1990).
  CAS PubMed Google Scholar
• Nguyen, S., Choi, H. K., Lustig, R. H. & Hsu, C. Y. Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. J. Pediatr. 154, 807–813 (2009).
  CAS PubMed PubMed Central Google Scholar
• D'Angelo, G., Elmarakby, A. A., Pollock, D. M. & Stepp, D. W. Fructose feeding increases insulin resistance but not blood pressure in Sprague-Dawley rats. Hypertension 46, 806–811 (2005).
  CAS PubMed Google Scholar
• Vasdev, S., Gill, V., Parai, S. & Gadag, V. Fructose-induced hypertension in Wistar-Kyoto rats: interaction with moderately high dietary salt. Can. J. Physiol. Pharmacol. 85, 413–421 (2007).
  CAS PubMed Google Scholar
• Tapia, E. et al. Synergistic effect of uricase blockade plus physiological amounts of fructose-glucose on glomerular hypertension and oxidative stress in rats. Am. J. Physiol. Renal Physiol. 304, F727–F736 (2013).
  CAS PubMed Google Scholar
• Weisbrod, R. M. et al. Arterial stiffening precedes systolic hypertension in diet-induced obesity. Hypertension 62, 1105–1110 (2013).
  CAS PubMed Google Scholar
• Madero, M., Perez-Pozo, S. E., Jalal, D., Johnson, R. J. & Sanchez-Lozada, L. G. Dietary fructose and hypertension. Curr. Hypertens. Rep. 13, 29–35 (2011).
  CAS PubMed Google Scholar
• He, F. J. & MacGregor, G. A. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J. Hum. Hypertens. 16, 761–770 (2002).
  CAS PubMed Google Scholar
• [No authors listed] Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. Intersalt Cooperative Research Group. BMJ 297, 319–328 (1988).
• Simopoulos, A. P. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed. Pharmacother. 56, 365–379 (2002).
  CAS PubMed Google Scholar
• Morris, M. C., Sacks, F. & Rosner, B. Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 88, 523–533 (1993).
  CAS PubMed Google Scholar
• Appel, L. J., Miller, E. R. 3rd, Seidler, A. J. & Whelton, P. K. Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. Arch. Intern. Med. 153, 1429–1438 (1993).
  CAS PubMed Google Scholar
• Hu, F. B. & Manson, J. E. Omega-3 fatty acids and secondary prevention of cardiovascular disease—is it just a fish tale?: comment on “Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease”. Arch. Intern. Med. 172, 694–696 (2012).
  CAS PubMed Google Scholar
• Appel, L. J. et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N. Engl. J. Med. 336, 1117–1124 (1997).
  CAS PubMed Google Scholar
• Hord, N. G., Tang, Y. & Bryan, N. S. Food sources of nitrates and nitrites: the physiologic context for potential health benefits. Am. J. Clin. Nutr. 90, 1–10 (2009).
  CAS PubMed Google Scholar
• Coles, L. T. & Clifton, P. M. Effect of beetroot juice on lowering blood pressure in free-living, disease-free adults: a randomized, placebo-controlled trial. Nutr. J. 11, 106 (2012).
  PubMed PubMed Central Google Scholar
• Siervo, M., Lara, J., Ogbonmwan, I. & Mathers, J. C. Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: a systematic review and meta-analysis. J. Nutr. 143, 818–826 (2013).
  CAS PubMed Google Scholar
• Moncada, S., Palmer, R. M. & Higgs, E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109–142 (1991).
  CAS PubMed Google Scholar
• Harris, K., Kassis, A., Major, G. & Chou, C. J. Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? J. Obes. 2012, 879151 (2012).
  PubMed PubMed Central Google Scholar
• Tilg, H. & Kaser, A. Gut microbiome, obesity, and metabolic dysfunction. J. Clin. Invest. 121, 2126–2132 (2011).
  CAS PubMed PubMed Central Google Scholar
• Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027–1031 (2006).
  PubMed Google Scholar
• Ley, R. E. et al. Obesity alters gut microbial ecology. Proc. Natl Acad. Sci. USA 102, 11070–11075 (2005).
  CAS PubMed PubMed Central Google Scholar
• Geurts, L. et al. Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front. Microbiol. 2, 149 (2011).
  CAS PubMed PubMed Central Google Scholar
• Murphy, E. F. et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 59, 1635–1642 (2010).
  CAS PubMed Google Scholar
• Shen, J., Obin, M. S. & Zhao, L. The gut microbiota, obesity and insulin resistance. Mol. Aspects Med. 34, 39–58 (2013).
  CAS PubMed Google Scholar
• Kootte, R. S. et al. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes. Metab. 14, 112–120 (2012).
  CAS PubMed Google Scholar
• Delzenne, N. M., Neyrinck, A. M., Backhed, F. & Cani, P. D. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat. Rev. Endocrinol. 7, 639–646 (2011).
  CAS PubMed Google Scholar
• Kurukulasuriya, L. R., Stas, S., Lastra, G., Manrique, C. & Sowers, J. R. Hypertension in obesity. Med. Clin. North Am. 95, 903–917 (2011).
  PubMed Google Scholar
• Slomko, H., Heo, H. J. & Einstein, F. H. Minireview: Epigenetics of obesity and diabetes in humans. Endocrinology 153, 1025–1030 (2012).
  CAS PubMed PubMed Central Google Scholar
• Sharma, A. M. Is there a rationale for angiotensin blockade in the management of obesity hypertension? Hypertension 44, 12–19 (2004).
  CAS PubMed Google Scholar
• Messerli, F. H. et al. Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. Arch. Intern. Med. 141, 81–85 (1981).
  CAS PubMed Google Scholar
• Strazzullo, P. et al. Altered renal sodium handling in men with abdominal adiposity: a link to hypertension. J. Hypertens. 19, 2157–2164 (2001).
  CAS PubMed Google Scholar
• McCurley, A. et al. Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors. Nat. Med. 18, 1429–1433 (2012).
  CAS PubMed PubMed Central Google Scholar
• Bender, S. B., McGraw, A. P., Jaffe, I. Z. & Sowers, J. R. Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease? Diabetes 62, 313–319 (2013).
  CAS PubMed PubMed Central Google Scholar
• Hayden, M. R. & Tyagi, S. C. Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle. Nutr. Metab. (Lond.) 1, 10 (2004).
  Google Scholar
• Zhong, J., Rao, X. & Rajagopalan, S. An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: potential implications in cardiovascular disease. Atherosclerosis 226, 305–314 (2013).
  CAS PubMed Google Scholar
• Schleithoff, C., Voelter-Mahlknecht, S., Dahmke, I. N. & Mahlknecht, U. On the epigenetics of vascular regulation and disease. Clin. Epigenetics 4, 7 (2012).
  PubMed PubMed Central Google Scholar
• Ordovas, J. M. & Smith, C. E. Epigenetics and cardiovascular disease. Nat. Rev. Cardiol. 7, 510–519 (2010).
  CAS PubMed PubMed Central Google Scholar
• Ortega, F. J. et al. Targeting the circulating microRNA signature of obesity. Clin. Chem. 59, 781–792 (2013).
  CAS PubMed Google Scholar
• Williams, M. D. & Mitchell, G. M. MicroRNAs in insulin resistance and obesity. Exp. Diabetes Res. 2012, 484696 (2012).
  PubMed PubMed Central Google Scholar
• Nistala, R. et al. Prenatal programming and epigenetics in the genesis of the cardiorenal syndrome. Cardiorenal Med. 1, 243–254 (2011).
  CAS PubMed PubMed Central Google Scholar
• Ganu, R. S., Harris, R. A., Collins, K. & Aagaard, K. M. Early origins of adult disease: approaches for investigating the programmable epigenome in humans, nonhuman primates, and rodents. ILAR J. 53, 306–321 (2012).
  PubMed PubMed Central Google Scholar
• Barker, D. J. Intrauterine programming of adult disease. Mol. Med. Today 1, 418–423 (1995).
  CAS PubMed Google Scholar
• Gillman, M. W. Developmental origins of health and disease. N. Engl. J. Med. 353, 1848–1850 (2005).
  CAS PubMed PubMed Central Google Scholar
• Femia, R. et al. Carotid intima-media thickness in confirmed prehypertensive subjects: predictors and progression. Arterioscler. Thromb. Vasc. Biol. 27, 2244–2249 (2007).
  CAS PubMed Google Scholar
• Cavalcante, J. L., Lima, J. A., Redheuil, A. & Al-Mallah, M. H. Aortic stiffness: current understanding and future directions. J. Am. Coll. Cardiol. 57, 1511–1522 (2011).
  PubMed Google Scholar
• Liao, D. et al. Arterial stiffness and the development of hypertension. The ARIC study. Hypertension 34, 201–206 (1999).
  CAS PubMed Google Scholar
• Aroor, A. R. et al. The role of tissue renin-angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness. Front. Endocrinol. 4, 161 (2013).
  Google Scholar
• Stenmark, K. R. et al. The adventitia: essential regulator of vascular wall structure and function. Ann. Rev. Physiol. 75, 23–47 (2013).
  CAS Google Scholar
• Sehgel, N. L. et al. Increased vascular smooth muscle cell stiffness; a novel mechanism for aortic stiffness in hypertension. Am. J. Physiol. Heart Circ. Physiol. 305, H1281–H1287 (2013).
  CAS PubMed PubMed Central Google Scholar
• Sandoo, A., van Zanten, J. J., Metsios, G. S., Carroll, D. & Kitas, G. D. The endothelium and its role in regulating vascular tone. Open Cardiovasc. Med. J. 4, 302–312 (2010).
  PubMed PubMed Central Google Scholar
• Li, R. et al. Vascular insulin resistance in prehypertensive rats: role of PI3-kinase/Akt/eNOS signaling. Eur. J. Pharmacol. 628, 140–147 (2010).
  CAS PubMed Google Scholar
• Muniyappa, R. & Sowers, J. R. Role of insulin resistance in endothelial dysfunction. Rev. Endocr. Metab. Disord. 14, 5–12 (2013).
  CAS PubMed PubMed Central Google Scholar
• Aroor, A. R., Mandavia, C. H. & Sowers, J. R. Insulin resistance and heart failure: molecular mechanisms. Heart Fail. Clin. 8, 609–617 (2012).
  PubMed PubMed Central Google Scholar
• Brillante, D. G., O'Sullivan, A. J. & Howes, L. G. Arterial stiffness in insulin resistance: the role of nitric oxide and angiotensin II receptors. Vasc. Health Risk Manag. 5, 73–78 (2009).
  PubMed PubMed Central Google Scholar
• DeMarco, V. G., Johnson, M. S., Whaley-Connell, A. T. & Sowers, J. R. Cytokine abnormalities in the etiology of the cardiometabolic syndrome. Curr. Hypertens. Rep. 12, 93–98 (2010).
  CAS PubMed Google Scholar
• Leal Vde, O. & Mafra, D. Adipokines in obesity. Clin. Chim. Acta 419, 87–94 (2013).
  PubMed Google Scholar
• Dorresteijn, J. A., Visseren, F. L. & Spiering, W. Mechanisms linking obesity to hypertension. Obes. Rev. 13, 17–26 (2012).
  CAS PubMed Google Scholar
• Brown, N. J. Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nat. Rev. Nephrol. 9, 459–469 (2013).
  CAS PubMed PubMed Central Google Scholar
• Johnson, R. J., Rodriguez-Iturbe, B., Kang, D. H., Feig, D. I. & Herrera-Acosta, J. A unifying pathway for essential hypertension. Am. J. Hypertens. 18, 431–440 (2005).
  PubMed Google Scholar
• Montecucco, F., Pende, A., Quercioli, A. & Mach, F. Inflammation in the pathophysiology of essential hypertension. J. Nephrol. 24, 23–34 (2011).
  PubMed Google Scholar
• Harrison, D. G., Marvar, P. J. & Titze, J. M. Vascular inflammatory cells in hypertension. Front. Physiol. 3, 128 (2012).
  CAS PubMed PubMed Central Google Scholar
• DeFronzo, R. A., Davidson, J. A. & Del Prato, S. The role of the kidneys in glucose homeostasis: a new path towards normalizing glycaemia. Diabetes Obes. Metab. 14, 5–14 (2012).
  CAS PubMed Google Scholar
• Kanai, Y., Lee, W. S., You, G., Brown, D. & Hediger, M. A. The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose. J. Clin. Invest. 93, 397–404 (1994).
  CAS PubMed PubMed Central Google Scholar
• Rahmoune, H. et al. Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. Diabetes 54, 3427–3434 (2005).
  CAS PubMed Google Scholar
• Tabatabai, N. M., Sharma, M., Blumenthal, S. S. & Petering, D. H. Enhanced expressions of sodium-glucose cotransporters in the kidneys of diabetic Zucker rats. Diabetes Res. Clin. Pract. 83, e27–e30 (2009).
  CAS PubMed Google Scholar
• Vallon, V. et al. Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus. Am. J. Physiol. Renal Physiol. 304, F156–F167 (2013).
  CAS PubMed Google Scholar
• Vallon, V., Richter, K., Blantz, R. C., Thomson, S. & Osswald, H. Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J. Am. Soc. Nephrol. 10, 2569–2576 (1999).
  CAS PubMed Google Scholar
• Lee, Y. J., Lee, Y. J. & Han, H. J. Regulatory mechanisms of Na(+)/glucose cotransporters in renal proximal tubule cells. Kidney Int. Suppl. 106, S27–S35 (2007).
  CAS Google Scholar
• Bautista, R. et al. Angiotensin II-dependent increased expression of Na+-glucose cotransporter in hypertension. Am. J. Physiol. Renal Physiol. 286, F127–F133 (2004).
  CAS PubMed Google Scholar
• Ghezzi, C. & Wright, E. M. Regulation of the human Na+-dependent glucose cotransporter hSGLT2. Am. J. Physiol. Cell Physiol. 303, C348–C354 (2012).
  CAS PubMed PubMed Central Google Scholar
• Ferrannini, E., Ramos, S. J., Salsali, A., Tang, W. & List, J. F. Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial. Diabetes Care 33, 2217–2224 (2010).
  PubMed PubMed Central Google Scholar
• Bailey, C. J., Gross, J. L., Pieters, A., Bastien, A. & List, J. F. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial. Lancet 375, 2223–2233 (2010).
  CAS PubMed Google Scholar
• Nauck, M. A. et al. Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial. Diabetes Care 34, 2015–2022 (2011).
  CAS PubMed PubMed Central Google Scholar
• Hall, J. E. et al. Impact of the obesity epidemic on hypertension and renal disease. Curr. Hypertens. Rep. 5, 386–392 (2003).
  PubMed Google Scholar
• O'Dea, K., Esler, M., Leonard, P., Stockigt, J. R. & Nestel, P. Noradrenaline turnover during under- and over-eating in normal weight subjects. Metabolism 31, 896–899 (1982).
  CAS PubMed Google Scholar
• Kassab, S. et al. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 25, 893–897 (1995).
  CAS PubMed Google Scholar
• Egan, B. M., Schork, N. J. & Weder, A. B. Regional hemodynamic abnormalities in overweight men. Focus on alpha-adrenergic vascular responses. Am. J. Hypertens. 2, 428–434 (1989).
  CAS PubMed Google Scholar
• Agapitov, A. V., Correia, M. L., Sinkey, C. A. & Haynes, W. G. Dissociation between sympathetic nerve traffic and sympathetically mediated vascular tone in normotensive human obesity. Hypertension 52, 687–695 (2008).
  CAS PubMed Google Scholar
• Lambert, G. W., Straznicky, N. E., Lambert, E. A., Dixon, J. B. & Schlaich, M. P. Sympathetic nervous activation in obesity and the metabolic syndrome—causes, consequences and therapeutic implications. Pharmacol. Ther. 126, 159–172 (2010).
  CAS PubMed Google Scholar
• Hall, J. E. et al. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J. Biol. Chem. 285, 17271–17276 (2010).
  CAS PubMed PubMed Central Google Scholar
• Lohmeier, T. E. & Iliescu, R. The sympathetic nervous system in obesity hypertension. Curr. Hypertens. Rep. 15, 409–416 (2013).
  PubMed PubMed Central Google Scholar
• Sawicki, P. T., Baba, T., Berger, M. & Starke, A. Normal blood pressure in patients with insulinoma despite hyperinsulinemia and insulin resistance. J. Am. Soc. Nephrol. 3, S64–S68 (1992).
  CAS PubMed Google Scholar
• Anderson, E. A., Hoffman, R. P., Balon, T. W., Sinkey, C. A. & Mark, A. L. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 87, 2246–2252 (1991).
  CAS PubMed PubMed Central Google Scholar
• Gao, Q. et al. Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc. Natl Acad. Sci. USA 101, 4661–4666 (2004).
  CAS PubMed PubMed Central Google Scholar
• Smith, M. M. & Minson, C. T. Obesity and adipokines: effects on sympathetic overactivity. J. Physiol. 590, 1787–1801 (2012).
  CAS PubMed PubMed Central Google Scholar
• Lurbe, E. et al. Added impact of obesity and insulin resistance in nocturnal blood pressure elevation in children and adolescents. Hypertension 51, 635–641 (2008).
  CAS PubMed Google Scholar
• Demarco, V. G. et al. Obesity-related alterations in cardiac lipid profile and nondipping blood pressure pattern during transition to diastolic dysfunction in male db/db mice. Endocrinology 154, 159–171 (2013).
  CAS PubMed Google Scholar
• Ohkubo, T. et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J. Hypertens. 20, 2183–2189 (2002).
  CAS PubMed Google Scholar
• Dangardt, F. et al. Reduced cardiac vagal activity in obese children and adolescents. Clin. Physiol. Funct. Imaging 31, 108–113 (2011).
  PubMed Google Scholar
• Silverberg, D. S. & Oksenberg, A. Are sleep-related breathing disorders important contributing factors to the production of essential hypertension? Curr. Hypertens. Rep. 3, 209–215 (2001).
  CAS PubMed Google Scholar
• Logan, A. G. et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J. Hypertens. 19, 2271–2277 (2001).
  CAS PubMed Google Scholar
• Lavie, P. & Hoffstein, V. Sleep apnea syndrome: a possible contributing factor to resistant. Sleep 24, 721–725 (2001).
  CAS PubMed Google Scholar
• Grassi, G. et al. Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension 46, 321–325 (2005).
  CAS PubMed Google Scholar
• Narkiewicz, K., van de Borne, P. J., Cooley, R. L., Dyken, M. E. & Somers, V. K. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98, 772–776 (1998).
  CAS PubMed Google Scholar
• Goodfriend, T. L. & Calhoun, D. A. Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension 43, 518–524 (2004).
  CAS PubMed Google Scholar
• Witkowski, A. et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension 58, 559–565 (2011).
  CAS PubMed Google Scholar
• McCurley, A., McGraw, A., Pruthi, D. & Jaffe, I. Z. Smooth muscle cell mineralocorticoid receptors: role in vascular function and contribution to cardiovascular disease. Pflugers Arch. 465, 1661–1670 (2013).
  CAS PubMed Google Scholar
• Ruster, C. & Wolf, G. The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases. Semin. Nephrol. 33, 44–53 (2013).
  PubMed Google Scholar
• Hall, J. E. et al. Hypertension: physiology and pathophysiology. Compr. Physiol. 2, 2393–2442 (2012).
  PubMed Google Scholar
• Hayden, M. R. et al. Possible mechanisms of local tissue renin-angiotensin system activation in the cardiorenal metabolic syndrome and type 2 diabetes mellitus. Cardiorenal Med. 1, 193–210 (2011).
  CAS PubMed PubMed Central Google Scholar
• Engeli, S., Negrel, R. & Sharma, A. M. Physiology and pathophysiology of the adipose tissue renin-angiotensin system. Hypertension 35, 1270–1277 (2000).
  CAS PubMed Google Scholar
• Kumar, R., Thomas, C. M., Yong, Q. C., Chen, W. & Baker, K. M. The intracrine renin-angiotensin system. Clin. Sci. (Lond.) 123, 273–284 (2012).
  CAS Google Scholar
• Szasz, T., Bomfim, G. F. & Webb, R. C. The influence of perivascular adipose tissue on vascular homeostasis. Vasc. Health Risk Manag. 9, 105–116 (2013).
  CAS PubMed PubMed Central Google Scholar
• Yiannikouris, F. et al. Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice. Hypertension 60, 1524–1530 (2012).
  CAS PubMed Google Scholar
• Bentley-Lewis, R. et al. Body mass index predicts aldosterone production in normotensive adults on a high-salt diet. J. Clin. Endocrinol. Metab. 92, 4472–4475 (2007).
  CAS PubMed Google Scholar
• Ehrhart-Bornstein, M., Arakelyan, K., Krug, A. W., Scherbaum, W. A. & Bornstein, S. R. Fat cells may be the obesity-hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells. Endocr. Res. 30, 865–870 (2004).
  CAS PubMed Google Scholar
• Ehrhart-Bornstein, M. et al. Human adipocytes secrete mineralocorticoid-releasing factors. Proc. Natl Acad. Sci. USA 100, 14211–14216 (2003).
  CAS PubMed PubMed Central Google Scholar
• Jeon, J. H. et al. A novel adipokine CTRP1 stimulates aldosterone production. FASEB J. 22, 1502–1511 (2008).
  CAS PubMed Google Scholar
• Blanco-Rivero, J. et al. Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats. Hypertension 46, 107–112 (2005).
  CAS PubMed Google Scholar
• Garg, R., Hurwitz, S., Williams, G. H., Hopkins, P. N. & Adler, G. K. Aldosterone production and insulin resistance in healthy adults. J. Clin. Endocrinol. Metab. 95, 1986–1990 (2010).
  CAS PubMed PubMed Central Google Scholar
• Kithas, P. A. & Supiano, M. A. Spironolactone and hydrochlorothiazide decrease vascular stiffness and blood pressure in geriatric hypertension. J. Am. Geriatr. Soc. 58, 1327–1332 (2010).
  PubMed PubMed Central Google Scholar
• Druppel, V. et al. Long-term application of the aldosterone antagonist spironolactone prevents stiff endothelial cell syndrome. FASEB J. 27, 3652–3659 (2013).
  PubMed Google Scholar
• Garg, R., Kneen, L., Williams, G. H. & Adler, G. K. Effect of mineralocorticoid receptor antagonist on insulin resistance and endothelial function in obese subjects. Diabetes Obes. Metab. 165, 268–272 (2014).
  Google Scholar
• Pulakat, L. et al. Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301, R885–R895 (2011).
  CAS PubMed PubMed Central Google Scholar
• Hwang, M. H. et al. Mineralocorticoid receptors modulate vascular endothelial function in human obesity. Clin. Sci. (Lond.) 125, 513–520 (2013).
  CAS Google Scholar
• Schafer, N. et al. Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity. Eur. Heart J. 34, 3515–3524 (2013).
  PubMed PubMed Central Google Scholar
• Byrd, J. B. & Brook, R. D. A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension. J. Hum. Hypertens. 28, 3–9 (2014).
  CAS PubMed Google Scholar
• Tomaschitz, A., Pilz, S., Ritz, E., Obermayer-Pietsch, B. & Pieber, T. R. Aldosterone and arterial hypertension. Nat. Rev. Endocrinol. 6, 83–93 (2010).
  CAS PubMed Google Scholar
• Ryan, M. J. An update on immune system activation in the pathogenesis of hypertension. Hypertension 62, 226–230 (2013).
  CAS PubMed Google Scholar
• Schiffrin, E. L. Immune mechanisms in hypertension and vascular injury. Clin. Sci. (Lond.) 126, 267–274 (2014).
  CAS Google Scholar
• Lumeng, C. N., Bodzin, J. L. & Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175–184 (2007).
  CAS PubMed PubMed Central Google Scholar
• Britton, K. A. & Fox, C. S. Perivascular adipose tissue and vascular disease. Clin. Lipidol. 6, 79–91 (2011).
  CAS PubMed PubMed Central Google Scholar
• Kalupahana, N. S., Moustaid-Moussa, N. & Claycombe, K. J. Immunity as a link between obesity and insulin resistance. Mol. Aspects Med. 33, 26–34 (2012).
  CAS PubMed Google Scholar
• Zhong, J. et al. T cell costimulation protects obesity-induced adipose inflammation and insulin resistance. Diabetes http://dx.doi.org/10.2337/db13-1094.
• Liu, G. et al. Phenotypic and functional switch of macrophages induced by regulatory CD4+CD25+ T cells in mice. Immunol. Cell Biol. 89, 130–142 (2011).
  CAS PubMed Google Scholar
• Kassan, M., Galan, M., Partyka, M., Trebak, M. & Matrougui, K. Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice. Arterioscler. Thromb. Vasc. Biol. 31, 2534–2542 (2011).
  CAS PubMed PubMed Central Google Scholar
• Ohshima, K. et al. Roles of interleukin 17 in angiotensin II type 1 receptor-mediated insulin resistance. Hypertension 59, 493–499 (2012).
  CAS PubMed Google Scholar
• Stienstra, R., Tack, C. J., Kanneganti, T. D., Joosten, L. A. & Netea, M. G. The inflammasome puts obesity in the danger zone. Cell Metab. 15, 10–18 (2012).
  CAS PubMed Google Scholar
• Akasheh, R. T., Pang, J., York, J. M. & Fantuzzi, G. New pathways to control inflammatory responses in adipose tissue. Curr. Opin. Pharmacol. 13, 613–617 (2013).
  CAS PubMed PubMed Central Google Scholar
• Rathinam, V. A., Vanaja, S. K. & Fitzgerald, K. A. Regulation of inflammasome signaling. Nat. Immunol. 13, 333–332 (2012).
  CAS PubMed PubMed Central Google Scholar
• Conforti-Andreoni, C. et al. Uric acid-driven Th17 differentiation requires inflammasome-derived IL-1 and IL-18. J. Immunol. 187, 5842–5850 (2011).
  CAS PubMed Google Scholar
• Guzik, T. J. et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 204, 2449–2460 (2007).
  CAS PubMed PubMed Central Google Scholar
• Kasal, D. A. et al. T regulatory lymphocytes prevent aldosterone-induced vascular injury. Hypertension 59, 324–330 (2012).
  CAS PubMed Google Scholar
• de Kloet, A. D. et al. Neuroimmune communication in hypertension and obesity: a new therapeutic angle? Pharmacol. Ther. 138, 428–440 (2013).
  CAS PubMed PubMed Central Google Scholar
• Harrison, D. G. et al. Inflammation, immunity, and hypertension. Hypertension 57, 132–140 (2011).
  CAS PubMed Google Scholar
• Abboud, F. M., Harwani, S. C. & Chapleau, M. W. Autonomic neural regulation of the immune system: implications for hypertension and cardiovascular disease. Hypertension 59, 755–762 (2012).
  CAS PubMed Google Scholar
• Dias da Silva, V. J. & Paton, J. F. Introduction: the interplay between the autonomic and immune systems. Exp. Physiol. 97, 1143–1145 (2012).
  PubMed Google Scholar
• Ganta, C. K. et al. Central angiotensin II-enhanced splenic cytokine gene expression is mediated by the sympathetic nervous system. Am. J. Physiol. Heart Circ. Physiol. 289, H1683–H1691 (2005).
  CAS PubMed Google Scholar
• Turak, O. et al. Serum uric acid, inflammation, and nondipping circadian pattern in essential hypertension. J. Clin. Hypertens. (Greenwich) 15, 7–13 (2013).
  CAS Google Scholar
• Perez-Pozo, S. E. et al. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. Int. J. Obes. (Lond.) 34, 454–461 (2010).
  CAS Google Scholar
• Chaudhary, K., Kunal, M., Sowers, J. & Aroor, A. Uric acid—key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med. 3, 208–220 (2013).
  CAS PubMed PubMed Central Google Scholar
• Baldwin, W. et al. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes 60, 1258–1269 (2011).
  CAS PubMed PubMed Central Google Scholar
• Mazzali, M. et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 38, 1101–1106 (2001).
  CAS PubMed Google Scholar
• Tran, L. T., Yuen, V. G. & McNeill, J. H. The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension. Mol. Cell. Biochem. 332, 145–159 (2009).
  CAS PubMed Google Scholar
• Aroor, A. et al. DPP-4 inhibitors as therapeutic modulators of immune cell function and associated cardiovascular and renal insulin resistance in obesity and diabetes. Cardiorenal Med. 3, 48–56 (2013).
  CAS PubMed PubMed Central Google Scholar
• Ussher, J. R. & Drucker, D. J. Cardiovascular biology of the incretin system. Endocr. Rev. 33, 187–215 (2012).
  CAS PubMed Google Scholar
• Lamers, D. et al. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 60, 1917–1925 (2011).
  CAS PubMed PubMed Central Google Scholar
• Wang, B. et al. Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials. Diabetes Obes. Metab. 15, 737–749 (2013).
  CAS PubMed Google Scholar
• Aroor, A. R. et al. Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin resistant male Zucker obese rats. Endocrinology 154, 2501–2513 (2013).
  CAS PubMed PubMed Central Google Scholar
• Kroller-Schon, S. et al. Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition. Cardiovasc. Res. 96, 140–149 (2012).
  PubMed Google Scholar
• Hocher, B., Reichetzeder, C. & Alter, M. L. Renal and cardiac effects of DPP4 inhibitors—from preclinical development to clinical research. Kidney Blood Press. Res. 36, 65–84 (2012).
  CAS PubMed Google Scholar
• Asferg, C. L. et al. Relative atrial natriuretic peptide deficiency and inadequate renin and angiotensin II suppression in obese hypertensive men. Hypertension 62, 147–153 (2013).
  CAS PubMed Google Scholar
• Yazbeck, R., Howarth, G. S. & Abbott, C. A. Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease? Trends Pharmacol. Sci. 30, 600–607 (2009).
  CAS PubMed Google Scholar
• Shirakawa, J. et al. Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice. Diabetes 60, 1246–1257 (2011).
  CAS PubMed PubMed Central Google Scholar
• Shah, Z. et al. Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis. Circulation 124, 2338–2349 (2011).
  CAS PubMed PubMed Central Google Scholar
• Hadjiyanni, I., Siminovitch, K. A., Danska, J. S. & Drucker, D. J. Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells. Diabetologia 53, 730–740 (2010).
  CAS PubMed Google Scholar
• McGill, J. B. et al. Potentiation of abnormalities in myocardial metabolism with the development of diabetes in women with obesity and insulin resistance. J. Nucl. Cardiol. 18, 421–429 (2011).
  PubMed Google Scholar
• Peterson, L. R. et al. Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J. Am. Coll. Cardiol. 43, 1399–1404 (2004).
  PubMed Google Scholar
• Manrique, C. et al. Obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a western diet. Endocrinology 154, 3632–3642 (2013).
  CAS PubMed PubMed Central Google Scholar
• Hinojosa-Laborde, C., Chapa, I., Lange, D. & Haywood, J. R. Gender differences in sympathetic nervous system regulation. Clin. Exp. Pharmacol. Physiol. 26, 122–126 (1999).
  CAS PubMed Google Scholar
• Johnson, M. S. et al. Sex differences in baroreflex sensitivity, heart rate variability, and end organ damage in the TGR(mRen2)27 rat. Am. J. Physiol. Heart Circ. Physiol. 301, H1540–H1550 (2011).
  CAS PubMed PubMed Central Google Scholar
• Denton, K. M., Hilliard, L. M. & Tare, M. Sex-related differences in hypertension: seek and ye shall find. Hypertension 62, 674–677 (2013).
  CAS PubMed Google Scholar
• Pal, S. & Radavelli-Bagatini, S. Association of arterial stiffness with obesity in Australian women: a pilot study. J. Clin. Hypertens. (Greenwich) 15, 118–123 (2013).
  CAS Google Scholar
• Berry, K. L. et al. Large-artery stiffness contributes to the greater prevalence of systolic hypertension in elderly women. J. Am. Geriatr. Soc. 52, 368–373 (2004).
  PubMed Google Scholar
• Scuteri, A. et al. Associations of large artery structure and function with adiposity: effects of age, gender, and hypertension. The SardiNIA Study. Atherosclerosis 221, 189–197 (2012).
  CAS PubMed Google Scholar
• Meyer, M. R., Clegg, D. J., Prossnitz, E. R. & Barton, M. Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol. (Oxf.) 203, 259–269 (2011).
  CAS Google Scholar
• Ribas, V. et al. Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development. Proc. Natl Acad. Sci. USA 108, 16457–16462 (2011)
  CAS PubMed PubMed Central Google Scholar
• Maric-Bilkan, C. & Manigrasso, M. B. Sex differences in hypertension: contribution of the renin-angiotensin system. Gend. Med. 9, 287–291 (2012).
  PubMed Google Scholar
• Lindsey, S. H., Yamaleyeva, L. M., Brosnihan, K. B., Gallagher, P. E. & Chappell, M. C. Estrogen receptor GPR30 reduces oxidative stress and proteinuria in the salt-sensitive female mRen2.Lewis rat. Hypertension 58, 665–671 (2011).
  CAS PubMed Google Scholar
• Ricchiuti, V. et al. Estradiol increases angiotensin II type 1 receptor in hearts of ovariectomized rats. J. Endocrinol. 200, 75–84 (2009).
  CAS PubMed Google Scholar
• Lindsey, S. H. & Chappell, M. C. Evidence that the G protein-coupled membrane receptor GPR30 contributes to the cardiovascular actions of estrogen. Gend. Med. 8, 343–354 (2011).
  PubMed PubMed Central Google Scholar
• Zhang, R. & Reisin, E. Obesity-hypertension: the effects on cardiovascular and renal systems. Am. J. Hypertens. 13, 1308–1314 (2000).
  CAS PubMed Google Scholar
• Smink, P. A. et al. An initial reduction in serum uric acid during angiotensin receptor blocker treatment is associated with cardiovascular protection: a post-hoc analysis of the RENAAL and IDNT trials. J. Hypertens. 30, 1022–1028 (2012).
  CAS PubMed Google Scholar
• Gupta, A. K. et al. Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk. J. Hypertens. 29, 2004–2013 (2011).
  CAS PubMed Google Scholar
• Mancia, G. et al. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J. Hypertens. 31, 1925–1938 (2013).
  CAS Google Scholar